All photos and content are copyright protected
[28] [29] This pharmacovigilance system enables ongoing safety monitoring and rapid identification of potential safety signals
What the trials show Key trial programs anchor the evidence: STEP evaluated semaglutide for weight management ( The New England Journal of Medicine , 2021), SURMOUNT evaluated tirzepatide for weight management (NEJM 2022), and SURMOUNT-OSA evaluated tirzepatide for obstructive sleep apnea (NEJM 2024)
Insomnia: Changes in appetite and metabolism can sometimes disrupt sleep patterns, leading to insomnia
The high ROS environment lowers the activation threshold of mast cells, causing them to degranulate inappropriately and release a flood of inflammatory cytokines, including histamine, interleukins, and tumor necrosis factor-alpha (TNF-a)
When you actually hit the bottom of a front squad is flexion and possibly compression